"At Sail Biomedicines, we are proud to have contributed to advancing the understanding of lipid nanoparticle surface structures," said Kerry Benenato, Ph.D., Chief Platform Officer at Sail ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results